Mark Nemeth is a highly experienced Psychiatry-Therapeutic Specialist at AbbVie since October 2016, with extensive expertise in the field of Psychiatry, specifically in antidepressants and atypical antipsychotics, accumulated over 29 years. Following a merger with Allergan in 2020, Mark earned multiple accolades, including the H1 Crystal Award in 2023 and the Q4 Crystal Award in 2022. Prior to AbbVie, Mark held various positions in sales and management roles at GSK, Pfizer, Fisons Pharmaceuticals, and Nordic Laboratories Inc., consistently demonstrating a strong sales performance and earning recognition for outstanding achievements. Mark holds a B.A. and B.P.E. degree in Business and Physical Education from Brock University, which was completed between 1985 and 1990.
This person is not in any teams
This person is not in any offices